List of Excipients in API mometasone furoate monohydrate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mometasone furoate monohydrate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | NASONEX | mometasone furoate monohydrate | 0085-1288 | BENZALKONIUM CHLORIDE | |
| Merck Sharp & Dohme Corp | NASONEX | mometasone furoate monohydrate | 0085-1288 | CARBOXYMETHYLCELLULOSE SODIUM | |
| Merck Sharp & Dohme Corp | NASONEX | mometasone furoate monohydrate | 0085-1288 | CELLULOSE, MICROCRYSTALLINE | |
| Merck Sharp & Dohme Corp | NASONEX | mometasone furoate monohydrate | 0085-1288 | CITRIC ACID MONOHYDRATE | |
| Merck Sharp & Dohme Corp | NASONEX | mometasone furoate monohydrate | 0085-1288 | GLYCERIN | |
| Merck Sharp & Dohme Corp | NASONEX | mometasone furoate monohydrate | 0085-1288 | POLYSORBATE 80 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing mometasone furoate monohydrate
Detailed excipient profiles for mometasone furoate monohydrate
Excipient focus: BENZALKONIUM CHLORIDE
mometasone furoate monohydrate drug variants containing BENZALKONIUM CHLORIDE
mometasone furoate monohydrate drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
mometasone furoate monohydrate drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
mometasone furoate monohydrate drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mometasone furoate monohydrate drug variants containing CELLULOSE, MICROCRYSTALLINE
mometasone furoate monohydrate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
mometasone furoate monohydrate drug variants containing CITRIC ACID MONOHYDRATE
mometasone furoate monohydrate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
mometasone furoate monohydrate drug variants containing GLYCERIN
mometasone furoate monohydrate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
mometasone furoate monohydrate drug variants containing POLYSORBATE 80
mometasone furoate monohydrate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
mometasone furoate monohydrate drug variants containing SODIUM CITRATE
mometasone furoate monohydrate drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | mometasone furoate monohydrate | 59651-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
mometasone furoate monohydrate drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | mometasone furoate monohydrate | 59651-402 |
| >Company | >Ingredient | >NDC |
mometasone furoate monohydrate drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
mometasone furoate monohydrate drug variants containing WATER
mometasone furoate monohydrate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | mometasone furoate monohydrate | 0085-1288 |
| Sandoz Inc | mometasone furoate monohydrate | 0781-6355 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
